Inspire Medical Systems INSP Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Inspire Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inspire Medical Systems's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inspire Medical Systems's cash & equivalents?
- Inspire Medical Systems (INSP) reported cash & equivalents of $98.93M in Q1 2026.
- How has Inspire Medical Systems's cash & equivalents changed year-over-year?
- Inspire Medical Systems's cash & equivalents increased by 83.6% year-over-year, from $53.88M to $98.93M.
- What is the long-term trend for Inspire Medical Systems's cash & equivalents?
- Over 5 years (2020 to 2025), Inspire Medical Systems's cash & equivalents has grown at a -11.3% compound annual growth rate (CAGR), from $190.52M to $104.81M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.